Arcus Biosciences (NYSE: RCUS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Arcus Biosciences (NYSE: RCUS) through any online brokerage.
The latest price target for Arcus Biosciences (NYSE: RCUS) was reported by SVB Leerink on Thursday, August 4, 2022. The analyst firm set a price target for 49.00 expecting RCUS to rise to within 12 months (a possible 74.50% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Arcus Biosciences (NYSE: RCUS) is $28.08 last updated August 15, 2022, 7:59 PM UTC.
There are no upcoming dividends for Arcus Biosciences.
Arcus Biosciences’s Q3 earnings are confirmed for Monday, November 7, 2022.
There is no upcoming split for Arcus Biosciences.
Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.